Article

Northfield Labs To Build First Manufacturing Site

Northfield Laboratories Inc. (Evanston, IL, www.northfieldlabs.com) has agreed to purchase a building it previously leased in Mt. Prospect, IL, to house its first commercial manufacturing facility to produce PolyHeme, Northfield?s human hemoglobin-based oxygen carrier, used to treat urgent, large-volume blood loss in trauma and surgical settings.

Northfield Laboratories Inc. (Evanston, IL, www.northfieldlabs.com) has agreed to purchase a building it previously leased in Mt. Prospect, IL, to house its first commercial manufacturing facility to produce PolyHeme, Northfield’s human hemoglobin-based oxygen carrier, used to treat urgent, large-volume blood loss in trauma and surgical settings. The company expects the plant to produce more than 100,000 units of PolyHeme annually. Northfield will pay $6.7 million for the property, which will also house laboratory, quality assurance, and administrative personnel.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
© 2025 MJH Life Sciences

All rights reserved.